FMS Q3 2023 Earnings Report — Fresenius Medical Care AG & Co. KGaA Revenue & Financial Results | Market Cap Arena

Fresenius Medical Care AG & Co. KGaAFMS

Q3 2023 Earnings

Reported September 29, 2023

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	Q3 2023	Q2 2023	Q3 2022	QoQ Change	YoY Change
Revenue	$5.8B	$5.6B	—	2.3%	—
Op. Income	$379M	$417M	—	-9.2%	—
Gross Margin	24.9%	24.8%	—	0.1pp	—
Net Margin	1.7%	2.9%	—	-1.2pp	—
EPS (Diluted)	$0.11	$0.19	—	-40.6%	—
Free Cash Flow	$728M	$996M	—	-26.9%	—

Revenue Flow

Item	Amount
REVENUE	$5.8B
Cost of Revenue	$4.3B
GROSS PROFIT	$1.4B
R&D Expenses	$62M
Selling & Marketing	$236M
General & Administrative	$692M
SG&A Expenses	$928M
Other Expenses	$68M
Operating Expenses	$1.1B
Cost & Expenses	$5.4B
OPERATING INCOME	$379M
Interest Income	$29M
Interest Expense	$133M
Other Income/Expenses	-$104M
INCOME BEFORE TAX	$275M
Income Tax Expense	$103M
Net Income from Continuing Ops	$172M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$98M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$98M
D&A	$531M
EBIT	$408M
EBITDA	$939M
EPS	$0
EPS Diluted	$0

Income Statement

Item	Amount
REVENUE	$5.8B
Cost of Revenue	$4.3B
GROSS PROFIT	$1.4B
R&D Expenses	$62M
Selling & Marketing	$236M
General & Administrative	$692M
SG&A Expenses	$928M
Other Expenses	$68M
Operating Expenses	$1.1B
Cost & Expenses	$5.4B
OPERATING INCOME	$379M
Interest Income	$29M
Interest Expense	$133M
Other Income/Expenses	-$104M
INCOME BEFORE TAX	$275M
Income Tax Expense	$103M
Net Income from Continuing Ops	$172M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$98M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$98M
D&A	$531M
EBIT	$408M
EBITDA	$939M
EPS	$0
EPS Diluted	$0

Cash Flow Statement

Item	Amount
Net Income	$99M
Depreciation & Amortization	$459M
Stock-Based Compensation	$0
Deferred Income Tax	$0
Other Non-Cash Items	$327M
Change in Working Capital	$3M
OPERATING CASH FLOW	$888M
Capital Expenditure	-$160M
Acquisitions (Net)	-$8M
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	-$9M
NET CASH FROM INVESTING	-$177M
Net Debt Issuance	$16M
Common Stock Repurchased	$0
Common Dividends Paid	$0
Other Financing Activities	-$498M
NET CASH FROM FINANCING	-$482M
FREE CASH FLOW	$728M
Net Change in Cash	$249M

Balance Sheet

Item	Amount
Cash & Equivalents	$1.8B
Short-Term Investments	$0
Net Receivables	$4.3B
Inventory	$2.7B
Other Current Assets	$1.7B
TOTAL CURRENT ASSETS	$10.6B
PP&E (Net)	$9.2B
Goodwill	$18.0B
Intangible Assets	$1.6B
Long-Term Investments	$824M
Tax Assets	$0
Other Non-Current Assets	$1.4B
TOTAL NON-CURRENT ASSETS	$31.1B
TOTAL ASSETS	$41.7B
Account Payables	$988M
Short-Term Debt	$1.5B
Deferred Revenue	$0
Other Current Liabilities	$4.3B
TOTAL CURRENT LIABILITIES	$7.7B
Long-Term Debt	$8.5B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$998M
Other Non-Current Liabilities	$1.9B
TOTAL NON-CURRENT LIABILITIES	$15.9B
TOTAL LIABILITIES	$23.6B
Common Stock	$343M
Additional Paid-In Capital	$3.9B
Retained Earnings	$12.6B
Treasury Stock	$0
Accum. Other Comp. Income	-$496M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$16.4B
Minority Interest	$1.7B
TOTAL EQUITY	$18.0B
TOTAL LIABILITIES & EQUITY	$41.7B
Total Debt	$15.2B
Net Debt	$13.4B